logo
Select company
Select metric
-42.02%Return on Assets
VS
Market
16
Sector
45
Industry
60
History
93
$ 0.74Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information

Ticker

XLO

Company Name

XILIO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XILIO THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XLO - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 133.81M$ -56.22M-42.02%
3/31/2025$ 103.72M$ -54.3M-52.36%
12/31/2024$ 71.08M$ -58.24M-81.94%
9/30/2024$ 74.66M$ -62.8M-84.12%
6/30/2024$ 89.87M$ -65.53M-72.92%
3/31/2024$ 82.61M$ -70.96M-85.9%
12/31/2023$ 60.93M$ -76.4M-125.4%
9/30/2023$ 77.84M$ -81.22M-104.33%
6/30/2023$ 92.36M$ -84.26M-91.23%
3/31/2023$ 111.5M$ -89.52M-80.28%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -152.05%.
  • Over the past 5 years, XILIO THERAPEUTICS INC's average ROA has been -78.06%.
  • The median ROA for XILIO THERAPEUTICS INC during this period was -80.28%
  • XILIO THERAPEUTICS INC reached its highest ROA over the past 5 years at -34.76%.
  • The lowest ROA recorded by XILIO THERAPEUTICS INC in the same timeframe -152.05%

XILIO THERAPEUTICS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
BRNS : BARINTHUS BIOTHERAPEUTICS PLC -53.59%BCAB : BIOATLA INC -219.38%GBIO : GENERATION BIO CO -40.36%CRIS : CURIS INC -133.13%EQ : EQUILLIUM INC -162.87%VVOS : VIVOS THERAPEUTICS INC -55.01%VRCA : VERRICA PHARMACEUTICALS INC -124.27%VERU : VERU INC -119.68%IRD : OPUS GENETICS INC -150.72%NEPH : NEPHROS INC 10.84%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for XILIO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -55.22M ] / Assets [ $ 36.32M ]
(=) ROA [ -152.05% ]

XLO - Return on Assets, Last 5 years

-152.05%

Minimum

Dec 31, 2020

-34.76%

Maximum

Dec 31, 2021

-78.06%

Average

-80.28%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.45K
min-33.42%
max33.98%
average0.1%
median1.53%
std10.63%